MCKENZIE BAUMAN: Open Payments
NPI 1548884380 · CONCORD, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,761 in 128 payments from 18 companies in 2025. Trend: 2023 $1,495 · 2024 $1,708 · 2025 $2,761
Food & beverage: $2,684Education: $77
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 22 | $714 |
| ABBVIE INC. | 31 | $525 |
| Gilead Sciences, Inc. | 16 | $301 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $227 |
| Aimmune Therapeutics, Inc. | 9 | $225 |
| GENZYME CORPORATION | 7 | $126 |
| PFIZER INC. | 6 | $101 |
| Regeneron Healthcare Solutions, Inc. | 4 | $99 |
| Phathom Pharmaceuticals, Inc. | 5 | $86 |
| Madrigal Pharmaceuticals | 3 | $72 |
Products named: TREMFYA, RINVOQ, ZENPEP, DUPIXENT, ENTYVIO, SKYRIZI, VOQUEZNA, REZDIFFRA.
Industry payments across NC — which companies pay providers there.
